We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEYE icon
1701
AudioEye
AEYE
$75.8M
$1.01M ﹤0.01%
+66,459
New +$1.52M
TAK icon
1702
Takeda Pharmaceutical
TAK
$56B
$1.01M ﹤0.01%
+76,254
New +$1.05M
BWA icon
1703
BorgWarner
BWA
$13B
$1.01M ﹤0.01%
31,734
+25,037
+374% +$852K
REPX icon
1704
Riley Exploration Permian
REPX
$716M
$1.01M ﹤0.01%
31,582
-19,094
-38% -$589K
UEIC icon
1705
Universal Electronics
UEIC
$58.1M
$1.01M ﹤0.01%
91,443
+394
+0.4% +$3.94K
SMTI icon
1706
Sanara MedTech
SMTI
$244M
$1.01M ﹤0.01%
+30,285
New +$1.03M
NVRI icon
1707
Enviri
NVRI
$623M
$1M ﹤0.01%
130,300
CAT icon
1708
Caterpillar
CAT
$387B
$1M ﹤0.01%
2,760
-59,336
-96% -$23M
KALV
1709
DELISTED
KalVista Pharmaceuticals
KALV
$999K ﹤0.01%
117,978
+103,072
+691% +$1.07M
FDN icon
1710
CALL
First Trust Dow Jones Internet Index Fund ETF
FDN
$5B
$997K ﹤0.01%
+4,100
New +$958K
BMI icon
1711
Badger Meter
BMI
$3.9B
$995K ﹤0.01%
4,691
-17,783
-79% -$3.87M
BKNG icon
1712
PUT
Booking.com
BKNG
$154B
$994K ﹤0.01%
5,000
-2,500
-33% -$481K
CUBI icon
1713
Customers Bancorp
CUBI
$2.69B
$991K ﹤0.01%
20,354
-46,673
-70% -$2.35M
LFCR icon
1714
Lifecore Biomedical
LFCR
$165M
$990K ﹤0.01%
133,191
-67,509
-34% -$431K
HG icon
1715
Hamilton Insurance Group
HG
$3.7B
$988K ﹤0.01%
51,922
-341,757
-87% -$6.32M
GH icon
1716
Guardant Health
GH
$19B
$980K ﹤0.01%
+32,085
New +$903K
SLGN icon
1717
Silgan Holdings
SLGN
$5.07B
$975K ﹤0.01%
18,730
+4,977
+36% +$265K
WTFC icon
1718
Wintrust Financial
WTFC
$10.9B
$968K ﹤0.01%
+7,761
New +$959K
EEM icon
1719
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
$966K ﹤0.01%
+23,100
New +$1.02M
GRBK icon
1720
Green Brick Partners
GRBK
$3.18B
$963K ﹤0.01%
17,051
+6,981
+69% +$496K
ACH
1721
Accendra Health
ACH
$249M
$963K ﹤0.01%
73,692
+56,192
+321% +$749K
IESC icon
1722
IES Holdings
IESC
$10.8B
$962K ﹤0.01%
4,788
-12,459
-72% -$3M
ADNT icon
1723
Adient
ADNT
$1.7B
$960K ﹤0.01%
+55,693
New +$1.11M
CRESY
1724
Cresud
CRESY
$808M
$959K ﹤0.01%
+76,542
New +$833K
ARI
1725
Apollo Commercial Real Estate
ARI
$881M
$956K ﹤0.01%
+110,434
New +$993K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.